Patents by Inventor Joseph GROSSO

Joseph GROSSO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-LAG-3 Antibodies to Treat Hematological Malignancies
    Publication number: 20240150459
    Abstract: Provided are methods for clinical treatment of hematological malignancies, such as relapsed or refractory chronic lymphocytic leukemia or lymphoma using an anti-LAG-3 antibody. Particular malignancies include, e.g., chronic lymphocytic leukemia (CLL), Hodgkin lymphoma (HL), or non-Hodgkin lymphoma (NHL).
    Type: Application
    Filed: July 28, 2023
    Publication date: May 9, 2024
    Inventors: Andres A. GUTIERREZ, Joseph GROSSO, Christopher Mark HILL, Mark J. SELBY, Katherine LEWIS
  • METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR
    Publication number: 20240124592
    Abstract: This disclosure provides a method for treating HPV-positive squamous cell carcinoma of the head and neck comprising administering to the subject an immune checkpoint inhibitor, e.g., an anti-PD-1 antibody or an anti-PD-L1 antibody. The disclosure also provides a method for treating HPV-negative squamous cell carcinoma of the head and neck administering to the subject an immune checkpoint inhibitor, e.g., an anti-PD-1 antibody or an anti-PD-L1 antibody. The subject can be additionally administered another anti-cancer agent.
    Type: Application
    Filed: July 26, 2023
    Publication date: April 18, 2024
    Applicant: Bristol-Myers Squibb Company
    Inventors: Demetrios MANEKAS, Joseph GROSSO, Jeffrey A. ANDERSON
  • Anti-LAG-3 Antibodies to Treat Hematological Malignancies
    Publication number: 20210122820
    Abstract: Provided are methods for clinical treatment of hematological malignancies, such as relapsed or refractory chronic lymphocytic leukemia or lymphoma using an anti-LAG-3 antibody. Particular malignancies include, e.g., chronic lymphocytic leukemia (CLL), Hodgkin lymphoma (HL), or non-Hodgkin lymphoma (NHL).
    Type: Application
    Filed: September 9, 2020
    Publication date: April 29, 2021
    Inventors: Andres A. GUTIERREZ, Joseph GROSSO, Christopher Mark HILL, Mark J. SELBY, Katherine E. LEWIS
  • METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR
    Publication number: 20200190198
    Abstract: This disclosure provides a method for treating HPV-positive squamous cell carcinoma of the head and neck comprising administering to the subject an immune checkpoint inhibitor, e.g., an anti-PD-1 antibody or an anti-PD-L1 antibody. The disclosure also provides a method for treating HPV-negative squamous cell carcinoma of the head and neck administering to the subject an immune checkpoint inhibitor, e.g., an anti-PD-1 antibody or an anti-PD-L1 antibody. The subject can be additionally administered another anti-cancer agent.
    Type: Application
    Filed: December 5, 2019
    Publication date: June 18, 2020
    Applicant: Bristol-Myers Squibb Company
    Inventors: Demetrios MANEKAS, Joseph GROSSO, Jeffrey A. ANDERSON
  • Method of treating cancer using immune checkpoint inhibitor
    Patent number: 10544224
    Abstract: This disclosure provides a method for treating HPV-positive squamous cell carcinoma of the head and neck comprising administering to the subject an immune checkpoint inhibitor, e.g., an anti-PD-1 antibody or an anti-PD-L1 antibody. The disclosure also provides a method for treating HPV-negative squamous cell carcinoma of the head and neck administering to the subject an immune checkpoint inhibitor, e.g., an anti-PD-1 antibody or an anti-PD-L1 antibody. The subject can be additionally administered another anti-cancer agent.
    Type: Grant
    Filed: July 14, 2016
    Date of Patent: January 28, 2020
    Assignee: Bristol-Myers Squibb Company
    Inventors: Demetrios Manekas, Joseph Grosso, Jeffrey Anderson
  • ANTI-LAG-3 ANTIBODIES TO TREAT HEMATOLOGICAL MALIGNANCIES
    Publication number: 20180244773
    Abstract: Provided are methods for clinical treatment of hematological malignancies, such as relapsed or refractory chronic lymphocytic leukemia or lymphoma using an anti-LAG-3 antibody. Particular malignancies include, e.g., chronic lymphocytic leulcemia (CLL), Hodgkin lymphoma (HL), or non-Hodgkin lymphoma (NHL).
    Type: Application
    Filed: February 9, 2018
    Publication date: August 30, 2018
    Inventors: Andres A. GUTIERREZ, Joseph GROSSO, Christopher Mark HILL, Mark J. SELBY, Katherine E. LEWIS
  • METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR
    Publication number: 20170037132
    Abstract: This disclosure provides a method for treating HPV-positive squamous cell carcinoma of the head and neck comprising administering to the subject an immune checkpoint inhibitor, e.g., an anti-PD-1 antibody or an anti-PD-L1 antibody. The disclosure also provides a method for treating HPV-negative squamous cell carcinoma of the head and neck administering to the subject an immune checkpoint inhibitor, e.g., an anti-PD-1 antibody or an anti-PD-L1 antibody. The subject can be additionally administered another anti-cancer agent.
    Type: Application
    Filed: July 14, 2016
    Publication date: February 9, 2017
    Applicant: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: Demetrios MANEKAS, Joseph Grosso, Jeffrey Anderson
  • TREATMENT OF HODGKIN'S LYMPHOMA USING AN ANTI-PD-1 ANTIBODY
    Publication number: 20160347836
    Abstract: This disclosure provides methods for treating Hodgkin's lymphoma in a subject comprising administering to the subject an anti-Programmed Death-1 (PD-1) antibody. In some embodiments, this invention relates to methods for treating Hodgkin's lymphoma in a subject comprising administering to the subject a combination of an anti-cancer agent which is an anti-Programmed Death-1 (PD-1) antibody and another anti-cancer agent such as an anti-Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) antibody.
    Type: Application
    Filed: May 26, 2016
    Publication date: December 1, 2016
    Inventor: Joseph Grosso
  • ANTI-LAG-3 ANTIBODIES TO TREAT HEMATOLOGICAL MALIGNANCIES
    Publication number: 20160326248
    Abstract: Provided are methods for clinical treatment of hematological malignancies, such as relapsed or refractory chronic lymphocytic leukemia or lymphoma using an anti-LAG-3 antibody. Particular malignancies include, e.g., chronic lymphocytic leukemia (CLL), Hodgkin lymphoma (HL), or non-Hodgkin lymphoma (NHL).
    Type: Application
    Filed: January 26, 2015
    Publication date: November 10, 2016
    Applicant: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: Andres A. GUTIERREZ, Joseph GROSSO, Christopher Mark HILL, Mark J. SELBY, Katherine E. LEWIS